AI-generated summary
This review describes the physical principles and practical considerations for using laser light to treat tumors and vascular malformations of the retina and choroid. The authors report that near-infrared wavelengths such as 810 nm and 1064 nm penetrate tissue well and are best suited for destroying tumors, while shorter wavelengths are more suitable for thin vascular formations. The abstract does not report patient outcomes.
- Who or what was studied
- Patients with tumors of the retina and choroid (such as retinoblastomas and malignant melanomas) and vascular malformations
- Wavelengths
- 810, 1064, 488, 514, 532 nm
- Limits stated in the abstract
- The abstract is a theoretical and practical review that reports no clinical outcome data or number of studies included.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 810 nm, 1064 nm, 514 nm, 532 nm
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Retina, Laser, Wavelength, Near-infrared, Irradiance. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.